Zobrazeno 1 - 1
of 1
pro vyhledávání: '"М. S. Pantyushenko"'
Autor:
S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borоzinets, A. A. Kazarov, М. S. Pantyushenko
Publikováno v:
Онкогематология, Vol 14, Iss 4, Pp 73-83 (2019)
Background. Currently, the main treatment for Gaucher disease is enzyme replacement therapy. Recombinant glucocerebrosidase (imiglu-cerase) is the first biotechnological drug for enzyme replacement therapy with proven clinical efficacy and safety for
Externí odkaz:
https://doaj.org/article/3727d50786d248acb2c75158dae94797
